|
[1]
|
X.-L. Ma, X.-F. Xu, C. Chen, et al. Epidemiology of respiratory distress and the illness severity in late preterm or term infants: A prospective multi-center study. Chinese Medical Journal, 2010, 123(20): 2776-2780.
|
|
[2]
|
F. S. Cole, A. Hamvas and L. M. Nogee. Genetic disorders of neonatal respiratory function. Pediatric Research, 2001, 50(2): 157- 162.
|
|
[3]
|
H.-Y. Yi, S. Xu and S.-J. Yang. Related factor analysis on term infant with respiratory distress syndrome. Chinese Journal of Neonatology, 2011, 26(5): 319-320.
|
|
[4]
|
L. Jain, D. C. Eaton. Physiology of fetal lung fluid clearance and the effect to labor. Seminars in Perinatology, 2006, 30(1): 34-43.
|
|
[5]
|
张巍, 童笑梅, 王丹华. 早产儿医学[M]. 北京: 人民卫生出版社, 2008: 53-58.
|
|
[6]
|
张国友, 朱科明, 邓小明. ARDS发病机制和治疗研究新进展[J].《国外医学》麻醉学与复苏分册, 2005, 26(2): 102-103.
|
|
[7]
|
M. Hogan, M. Kuliszewski, W. Lee, et al. Regulation of phospatidycholine synthesis inmaturing type II cells: Increased mRNA stability of CTP: Phosphocholine cytidylyltransferase. Bioche- mical Journal, 1996, 314: 799-803.
|
|
[8]
|
E. P. Davis, E. L. Townsend, M. R. Gunnar, et al. Effects of prenatal betamethasone exposure on regulation of stress physiology in healthy premature infants. Psychoneuroendocrinology, 2004, 29(8): 1028-1036.
|
|
[9]
|
G. Gragic, Z. Fatusic and G. Bogdanovic. Stimulation of fetal maturation with dexamethasone in unexpected premature labor. Medical Archives, 2003, 57(5-6): 291-294.
|
|
[10]
|
J. B. Laoag-Femandez, A. M. Femandez and T. Maruo. Antenatal use of ambroxol for the prevention of infant respiratory distress syndrome. Journal of Obstetrics and Gynaecology Research, 2000, 26(4): 307-312.
|
|
[11]
|
C. Dani, P. V. Grella, L. Lazzarin, et al.•Antenatal ambroxol treatment does not prevent the respiratory distress syndrome in premature infants. European Journal of Pediatrics, 1997, 156(5): 392-393.
|
|
[12]
|
S. Ruocco, A. Lallemand, J. M. Tounier, et al. Expression and localization of epidermal growth factor, transfering growth factor-a, and localization of their common receptor in fetal human lung development. Pediatric Research, 1996, 39: 448.
|
|
[13]
|
A. Andreas, J. Frans, C. Waltherb, A. J. Waring, et al. Synthetic surfactant based on analogues of SP-B and SP-C is superior to single-peptide surfactants in ventilated premature rabbits. Neonatology, 2010, 98(1): 91-99.
|
|
[14]
|
P. Timothy, M. D. Stevens. Surfactant replacement therapy. Chest, 2007, 131(5): 1577-1582.
|
|
[15]
|
D. G. Sweet, V. Carnielli, G. Greisen, et al. The prevention and treatment of neonatal distress syndrome in European. Chinese Journal of Contemporary Pediatrics, 2011, 49(1): 27-33.
|
|
[16]
|
M. Mario, R. Beatrice. Ambroxol in the 21st century: Pharmacological and clinical update. Expert Opinion on Drug Metabolism & Toxicology, 2008, 4(8): 1119-1129.
|
|
[17]
|
K. M. Beeh, J. Beier, A. Esperester and D. Paul. Antiinflammatory properties of ambroxol. European Journal of Medical Research, 2008, 13(12): 557-562.
|
|
[18]
|
邝土光, 张洪玉, 庞宝森等. 氨溴索弱化机体氧化/抗氧化失衡的实验与临床观察[J]. 中华医学杂志, 2001, 81(8): 506- 507.
|
|
[19]
|
L. Andreas, R. Jennifer and N. Carla. Block of sensory neuronal Na+ channels by the secreolytic ambroxol is associated with an interaction with local anesthetic binding sites. European Journal of Pharmacology, 2010, 630(1-3): 19-28.
|
|
[20]
|
C. J. Morley, G. Peter, et al. Nasal CPAP or intubation at birth for very preterm infants. New England Journal of Medicine, 2008, 358(7): 700-708.
|
|
[21]
|
A. R. Mario, M. L. Juan and X. R. Maria. Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: A randomized, controlled trial. Pediatrics, 2009, 123(1): 137-142.
|
|
[22]
|
E. C. Shannon, L. Katherine and C. P. Fedor. Effects of imposed resistance on tidal volume with 5 neonatal nasal continuous po- sitive airway pressure systems. Respiratory Care, 2010, 55(5): 544-548.
|
|
[23]
|
G.-J. Chen, L. Guo and Z.-Y. Xiao. A comparative study on early applying of B-NCPAP 8 cm H2O with PS plus B-NCPAP 5 cm H2O in neonatal respiratory distress syndrome. Chinese Journal of Evidence Based Pediatrics, 2009, l4(5): 295-300.
|
|
[24]
|
Y.-P. Cui, X.-M. Tong, H.-M. Ye, et al. A meta analysis of nasal intermittent positive pressure ventilation in treatment of respiratory distress syndrome in premature infants. Chinese Journal of Pediatrics, 2009, 47(7): 532-535.
|
|
[25]
|
H. K. Vonder, M. A. Kandler, L. Fink, et al. High-frequency oscillation ventilation suppresses inflammatory response in lung tissue and microdissected alveolar macrophages in surfactant depleted piglets. Pediatrics Research, 2003, 55(2): 1-8.
|
|
[26]
|
Z.-J. Liu, S.-T. Li, H. Hao, et al. The safety analysis of high- frequency oscillatory ventilation for neonatal respiratory distress syndrome. Journal of Clinical Pediatrics, 2008, 26(3): 191-194.
|
|
[27]
|
J. N. Ben, K. Mnif, A. Khaldi, et al. High-frequency oscillatory ventilation in term and near-term infants with acute respiratory failure: Early rescue use. American Journal of Perinatology, 2006, 23(7): 403-411.
|
|
[28]
|
T. T. Colaizy, U. M. Younis and E. F. Bell. Nasal high-frequency ventilation for premature infants. Acta Paediatrica, 2008, 97(11): 1518-1522.
|
|
[29]
|
F. Cools, L. M. Askie and M. Offringa. Elec-tive high-frequency oscillatory ventilation in preterm infants with respiratory distress syndrome: An individual patient data meta-analysis. BMC Pediatr, 2009, 16(9): 33.
|
|
[30]
|
Q. Yang, B. Sun. Experimental research and clinical application of inhaled nitric oxide in premature neonates. Journal of Clinical Pediatric, 2009, 27(3): 210-213.
|
|
[31]
|
S. Hosono, T. Ohno and H. Kimoto. Developmental outcomes in persistent pulmonary hypertension treated with nitric oxide therapy. Pediatrics Interantional, 2009, 51(1): 79-83.
|
|
[32]
|
Y. J. Lin, N. E. Markham, V. Balasubramaniam, et al. Inhaled nitric oxide enhances distal lung growth after exposure to hyperoxia in neonatal rats. Pediatric Research, 2005, 58(1): 22-29.
|
|
[33]
|
K. J. Barrington, N. Finer. Inhaled nitric oxide for respiratory failure in preterm infants. Pediatrics, 2011, 128(1): 255-256.
|
|
[34]
|
J. C. Mercier, H. Hummler, X. Durrmeyer, M. Sanchez-Luna, et al. Inhaled nitric oxide for prevention of bronchopulmonary dysplasia in premature babies (EUNO): A randomised controlled trial. Lancet, 2010, 376(9738): 346-354.
|
|
[35]
|
H. Chang, F. C. Kuo, Y. S. Lai, et al. Inhibition of inflammatory responses by FC-77, a Perfluorochemicalin lipopolysaccharide- treated RAW264.7 macrophages. Intensive Care Medicine, 2005, 31(7): 977-984.
|
|
[36]
|
Y.-B. Zhu, Q. Wang, Y.-L. Liu, et al. Effect of partial liquid ventilation on oleic ac-id-induced inflammatory responses in piglets. Chinese Medical Journal, 2010, 123(15): 2088-2093.
|
|
[37]
|
M. R. Wolfson, R. B. Hirschl, J. C. Jackson, et al. Multicenter comparative study of conventional mechanical gas ventilation to tidal liquid ventilation in oleic acid injured sheep. ASAIO Journal, 2008, 54(3): 256-269.
|
|
[38]
|
S. Liu, L. B. Sun, Y. H. Mi, et al. Extracorporeal membrane oxygenation (ARDS) in patients of different causes. Journal of Cardiovascular and Pulmonary Diseases, 2011, 30(1): 8-12.
|
|
[39]
|
J. R. Pohlmann, D. O. Brant, M. A. Daul, et al. Total liquid ventilation provides superior respiratory support to con-ventional mechanical ventilation in a large animal model of severe respiratory failure. ASAIO Journal, 2011, 57(1): 1-8.
|
|
[40]
|
C. Long. The opportunities and challenges of extracorporeal membrane oxygenation on Chinese cardiopulmonary bypass in this century. Chinese Journal of Extracorporeal Circulation, 2005, 3(2): 65.
|
|
[41]
|
Y.-H. Chen, B.-D. Zhang, D.-K. Liang, et al. Treatment of extracorporeal membrane oxygenation on acute lung injury. China Journal of Modern Medicine, 2011, 21(19): 2215-2218.
|
|
[42]
|
T. Schaible, D. Hermle, F. Loersch, et al. A 20-year experience on neonatal extracorporeal membrane oxygenation in a referral center. Intensive Care Medicine, 2010, 36(7): 1229-1234.
|
|
[43]
|
E. Khoshbin, D. Machin, H. Killer, et al. A potential propensity for failure secondary to clot embolism in neonatal ECMO. Perfusion, 2005, 20(3): 177-181.
|